Medroxyprogesterone Acetate Injection, Suspension, Extended Release
Product Images NDC 0548-5701

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Medroxyprogesterone Acetate (NDC 0548-5701). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amphastar Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton 5400

FDA Label Image

Carton 5401

FDA Label Image

Carton 5701

Carton 5701
This is a product label for MedroxyPROGESTERone ACETATE Injectable Suspension, which is a medication used for contraception and hormonal imbalance treatment. The label includes information about dosage (1w/Bw gs1) and cautionary text ("NOISNIdsnS"). There is also an expiration date (318Y1930N1 31¥139Y) and a reference code (8043153904 dAX0IPBN). However, the text is not properly formatted and some characters are not recognizable, likely due to errors.*
FDA Label Image

Structure

FDA Label Image

Chart

Chart
This is a chart or diagram displaying the effectiveness of different birth control methods. It includes information on the number of pregnancies per 100 women in one year for each method listed. The methods are divided into four categories: Long-acting reversible contraceptives, hormonal methods, barrier methods, and natural methods. The chart also suggests that using no birth control is not an effective method for pregnancy prevention.*
FDA Label Image

Figure1and2

FDA Label Image

Risk Estimate

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.